Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/31875
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bhuiya, AR | - |
dc.contributor.author | Bain, T | - |
dc.contributor.author | Wang, Q | - |
dc.contributor.author | Al-Khateeb, S | - |
dc.contributor.author | DeMaio, P | - |
dc.contributor.author | Ahmad, A | - |
dc.contributor.author | Drakos, A | - |
dc.contributor.author | Rintjema, J | - |
dc.contributor.author | Sharma, K | - |
dc.contributor.author | Matthews, M | - |
dc.contributor.author | Gauvin, François-Pierre | - |
dc.contributor.author | Lavis, JN | - |
dc.contributor.author | Wilson, MG | - |
dc.date.accessioned | 2025-06-26T20:21:15Z | - |
dc.date.available | 2025-06-26T20:21:15Z | - |
dc.date.issued | 2021-05 | - |
dc.identifier.citation | Bhuiya A, Bain T, Wang Q, Al-Khateeb S, DeMaio P, Ahmad A, Drakos A, Rintjema J, Sharma K, Matthews M, Gauvin FP, Lavis JN, Wilson MG. COVID-19 living evidence profile #1 (version 1.7): What is known about anticipated COVID-19 vaccine roll-out elements? Hamilton: McMaster Health Forum, 28 May 2021. | en_US |
dc.identifier.uri | http://hdl.handle.net/11375/31875 | - |
dc.description.abstract | An overview of the best available research evidence from around the world (i.e., evidence syntheses) and local research evidence (i.e., single studies) and, if applicable, a scan of experiences from other countries and from Canadian provinces and territories, about anticipated COVID-19 vaccine roll-out elements in response to a decision-maker’s request. | en_US |
dc.description.sponsorship | The COVID-19 Evidence Network to support Decision-making (COVID-END) is supported by an investment from the Government of Canada through the Canadian Institutes of Health Research (CIHR). | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartofseries | LEP 1.7; | - |
dc.subject | COVID-19 | en_US |
dc.subject | vaccine | en_US |
dc.subject | roll-out | en_US |
dc.title | COVID-19 living evidence profile #1 (version 1.7): What is known about anticipated COVID-19 vaccine roll-out elements? | en_US |
Appears in Collections: | Living evidence profile |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
COVID-19 living evidence profile 1.7_What is known about anticipated COVID-19 vaccine roll-out elements.pdf | 850.74 kB | Adobe PDF | View/Open | |
COVID-19 living evidence profile 1.7-appendix_What is known about anticipated COVID-19 vaccine roll-out elements.pdf | 1.82 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License